PPT-Original Article Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism

Original Article LowDose Aspirin for Preventing Recurrent Venous Thromboembolism Timothy A Brighton MB BS John W Eikelboom MB BS Kristy Mann MBiostat Rebecca Mister MSc Alexander Gallus MB BS Paul Ockelford MB Harry Gibbs MB Wendy Hague PhD Denis Xavier MSc Rafael Diaz MD Adrienne Kirby MSc John Simes MD for the ASPIRE Investigators. how long to treat?. Eliot Williams, MD PhD. Department of Medicine. Division of Hematology & Medical Oncology. 3 months of anticoagulant treatment is both necessary and sufficient for most patients after a first episode of VTE. Thromboembolism. N . Engl. J Med. 2012;366:1959-67. VTE Prevalence. Incidence . of DVT: 48 per 100,000. Incidence of PE: 23 per 100,000. Case-fatality rate. Inpatient: 12%. 1-year: 19%; 3-year: 30%. (EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS. PGY2 Cardiology Resident. WakeMed. Health & . Hosptials. Raleigh, NC. Dr. . Ryan Sparks (presenter). Current PGY2 Cardiology Resident at . WakeMed. Stacey Graven, ACNP. Vascular Surgery, Springfield Clinic. Springfield, Illinois. VTE. In September 2008, Surgeon General issued a “Call to Action to Prevent Deep Venous Thrombosis and Pulmonary Embolis. Judicious Use of Anticoagulation: A Case-Based Approach Michael B. Streiff, MD, FACP Associate Professor of Medicine and Pathology Division of Hematology Medical Director, Johns Hopkins Anticoagulation Management Service and Outpatient Clinics Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators Weitz JI et al. N Engl J Med 2017 ( In Press) Rivaroxaban or Aspirin for Extended Treatment of Venous  Thromboembolism Objectives. Define VTE and discuss the incidence of VTE. Articulate risk factors for VTE. Discuss primary and secondary prevention. Review current guidelines. A Case…. A 12-year-old male with history of intractable epilepsy underwent right-sided craniotomy with grid placement for seizure mapping. He has a PICC line in place due to difficult IV access, and he is on bedrest. An Educational Slide Set . American Society of Hematology 2018 Guidelines . for Management of Venous Thromboembolism. Slide set authors: . Eric Tseng MD . MScCH. , University of Toronto. Wendy Lim MD MSc, McMaster University. 89 non-cardioembolic stroke detected by rapid platelet function analyzer Jose C NAVARRO MD MSc , Annabelle Y LAO MD , Maricar P YUMUL MD , Maria Leticia C ARAULLO MD , Johnny K LOKIN MD , Aleja VOLUME 32 MBE ECEMBE 2009www.australianprescriber.com molecular weight heparin or oral warfarin reduces the risk of venous thromboembolism. Low molecular weight heparin injected immediately be - Associated Venous Thromboembolism A Guide for Effective Quality Improvement Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road R and . arterial. . thrombosis. Walter Ageno. Department of Clinical Medicine. University of Insubria. Varese - Italy. Asymptomatic atherosclerosis . and deep vein thrombosis. . A. therosclerosis. . karim. Roosevelt University . Definition/Signs and Symptoms. Deep vein thrombosis (DVT) – blood clot occurring in a deep vein. Classified as distal or proximal. Pulmonary embolism (PE) – blood clot occurring in artery of the lung. Thromboembolism. Jatheesh mohan. BACKGROUND. Factor . XIa. inhibitors for the prevention and treatment of venous and arterial thromboembolism may be more effective and result in less bleeding than conventional anticoagulants..